Enhancing open clinical trials through blinded evaluations: an exploration with diabetic foot infections.

ABSTRACT:

Background

Blinding drugs through simulation techniques is an important means to control the subjective bias of investigators and subjects. However, clinical trials face significant challenges in the placebo production of drugs, and many trials cannot be double-blinded.

Objective

This study was conducted to ascertain the consistency between non-blind and blind evaluation results in clinical trials and to pioneer strategies to control information bias, particularly in trials where double-blinding is not feasible.

Methods

In this investigation, a randomized controlled trial (RCT) studying diabetic foot infections (DFIs) was utilized as a representative case. In this trial, the grading of DFIs, as per guidelines by the Infectious Disease Society of America (IDSA) and Int

SUBMITTER: Li Q 

PROVIDER: S-EPMC10636892 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature